#MedCase - A rare report of fatal European subtype tick-borne encephalitis in a child.
TBE should be considered in the differential diagnosis of neurological symptoms in highly endemic areas, regardless of vaccination status or presence of fever.
👉️ buff.ly/OcJAFDF
#IDSky #NeuroSky
Long-acting #GrowthHormone preparations, administered once weekly, have demonstrated efficacy and safety comparable to daily treatment in clinical trials, but do they enhance treatment adherence in real-world settings?
👉️ buff.ly/6hefkBD
#EndoSky #PediatricMed
The evolving therapeutic landscape of advanced #HCC has led to an increasing number of patients receiving second-line and subsequent therapies.
But what are the best treatment options in these later lines?
👉️ buff.ly/HfRsAXL
#OncSky #GISky
From #ASCO2026 - Dr. Tanya Dorff shares the most important #ProstateCancer studies of the past year, spotlighting the themes of treatment intensification and the use of PARP inhibitors and radiopharmaceuticals in earlier stages of disease.
👉️ buff.ly/XWnPWIO
#OncSky
#MedCase - Lifelong endothelial monitoring is essential after iris-fixated anterior chamber phakic intraocular lens implantation
In this case, bullous keratopathy emerged 12 years after surgery.
👉️ buff.ly/mEe7SmH
#EyeSky #LensSurgery
New biological insights and pivotal clinical trials are reshaping the treatment of #BladderCancer, especially in #NMIBC and #MIBC.
In this free webinar, Prof. Guru Sonpavde and Prof. @axelmerseburger.bsky.social provide an overview of the evolving standards of care.
👉️ buff.ly/6uOWY8L
--
#OncSky
From #ADA2026 - Cagrilintide–semaglutide therapy improves HbA1C levels in #Type2Diabetes that has been inadequately controlled with basal insulin given alone or alongside metformin.
👉️ buff.ly/5n5mFiS
#T2D
Long-acting growth hormone preparations, administered once weekly, have demonstrated efficacy and safety comparable to daily treatment in clinical trials, but do they enhance treatment adherence in…
springermedicine.com
A rare case of fulminant European subtype tick-borne encephalitis in a fully vaccinated, immunocompetent child. TBE should be considered in the differential diagnosis of neurological symptoms in…
Get insights into the safety and efficacy of #MRAs in #HeartFailure with reduced, mildly reduced, and preserved ejection fractions, including in the context of kidney disease.
👉️ buff.ly/lBM631W
#CardioSky
Lifelong endothelial monitoring is essential after iris-fixated anterior chamber phakic intraocular lens implantation. In this case, bullous keratopathy emerged 12 years after surgery.
www.springermedicine.com
Cagrilintide–semaglutide (CagriSema) therapy improves HbA1C levels in type 2 diabetes that has been inadequately controlled with basal insulin given alone or alongside metformin.
buff.ly
Insights into the safety and efficacy of mineralocorticoid receptor antagonists in heart failure with reduced, mildly reduced, and preserved ejection fractions, including in the context of kidney…
From #ADA2026 - The triple hormone receptor agonist #retatrutide significantly improves glycemic control and bodyweight in people with early #Type2Diabetes.
👉️ buff.ly/GyG7Sds
#T2D
Micro- and nano-plastic exposure represents an emerging and complex risk factor for #ASCVD.
But what factors shape individual-level exposure? And how could these exposures impact ASCVD development?
👉️ buff.ly/CSJQkcX
#CardioSky #Microplastics
Springer Medicine
Springer Medicine
Springer Medicine
Springer Medicine
Springer Medicine
Springer Medicine
Springer Medicine
Springer Medicine
The triple hormone receptor agonist retatrutide significantly improves glycemic control and bodyweight in people with early type 2 diabetes.
Micro- and nano-plastic exposure represents an emerging and complex risk factor for atherosclerotic cardiovascular. But what factors shape individual-level exposure? And how could these exposures…
The evolving therapeutic landscape of advanced hepatocellular carcinoma has led to an increasing number of patients receiving second-line and subsequent therapies. But what are the best treatment…
